Cite

HARVARD Citation

    Rhee, M. et al. (2017). The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia. BMC pharmacology & toxicology. 18 (1), pp. 1-11. [Online]. 
  
Back to record